Clinical Spectrum of Cutaneous Adverse Drug Reactions in HIV Patients: A Literature Review Espridelavia Sektiara1, Afif Nurul Hidayati2*, Arifa Mustika3 Abstract Cutaneous Adverse Drug Reactions (CADRs) represent a significant clinical concern among individuals living with Human Immunodeficiency Virus (HIV), who exhibit heightened susceptibility due to profound immune dysregulation, declining CD4+